2-naphthylamine has been researched along with Alzheimer Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Li, R; Lv, G; Sun, A; Wang, M; Wei, P; Yi, T | 1 |
Andrikopoulos, N; Davis, TP; Ding, F; Kakinen, A; Ke, PC; Kwak, E; Leong, DT; Li, Y; Nandakumar, A; Sun, Y; Tang, H; Wang, D; Zhu, H | 1 |
Cvačka, J; Maletínská, L; Popelová, A; Pražienková, V; Strnad, Š; Sýkora, D; Vrkoslav, V | 1 |
Fa, H; Hou, C; Huo, D; Yin, W; Zhang, D; Zhang, H; Zhang, J; Zhou, J | 1 |
Diao, XW; Fa, HB; Li, S; Yin, W; Zhang, D; Zhou, JT | 1 |
Cui, M; Dai, J; Fu, H; Liu, B; Tu, P; Zhao, L; Zhou, K | 1 |
Agdeppa, ED; Barrio, JR; Ceh, S; Golobic, A; Houk, KN; Johnson, SA; Kepe, V; Keum, G; Li, Y; Liu, J; Petric, A; Pham, HV; Satyamurthy, N; Timbol, G | 1 |
7 other study(ies) available for 2-naphthylamine and Alzheimer Disease
Article | Year |
---|---|
A novel near-infrared fluorescent probe for detection of early-stage Aβ protofibrils in Alzheimer's disease.
Topics: 2-Naphthylamine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Female; Fluorescent Dyes; Limit of Detection; Male; Mice, Inbred C57BL; Mice, Transgenic; Molecular Docking Simulation; Molecular Dynamics Simulation; Nitriles; Spectrometry, Fluorescence | 2020 |
Ultrasmall Molybdenum Disulfide Quantum Dots Cage Alzheimer's Amyloid Beta to Restore Membrane Fluidity.
Topics: 2-Naphthylamine; Actins; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Membrane; Disulfides; Humans; Hydrophobic and Hydrophilic Interactions; Laurates; Membrane Fluidity; Microscopy, Confocal; Molecular Dynamics Simulation; Molybdenum; Nanomedicine; Quantum Dots | 2021 |
The use of 1,5-diaminonaphthalene for matrix-assisted laser desorption/ionization mass spectrometry imaging of brain in neurodegenerative disorders.
Topics: 2-Naphthylamine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Gangliosides; Glycerophospholipids; Male; Mice, Inbred C57BL; Reproducibility of Results; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; tau Proteins | 2019 |
Synthesis of superparamagnetic iron oxide nanoparticles coated with a DDNP-carboxyl derivative for in vitro magnetic resonance imaging of Alzheimer's disease.
Topics: 2-Naphthylamine; Alzheimer Disease; Amyloid beta-Peptides; Contrast Media; Dextrans; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Peptide Fragments; Protein Binding; Radiography; Surface Properties | 2014 |
The detection of β-amyloid plaques in an Alzheimer's disease rat model with DDNP-SPIO.
Topics: 2-Naphthylamine; Acrylonitrile; Alzheimer Disease; Animals; Case-Control Studies; Coloring Agents; Congo Red; Contrast Media; Disease Models, Animal; Ferrocyanides; Hippocampus; Magnetic Resonance Imaging; Magnetite Nanoparticles; Plaque, Amyloid; Rats; Spectrometry, Fluorescence | 2015 |
Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer's Disease.
Topics: 2-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Brain; Female; Fluorescent Dyes; Humans; Male; Mice, Inbred ICR; Mice, Transgenic; Middle Aged; Molecular Docking Simulation; Nitriles; Plaque, Amyloid; Protein Binding; Spectroscopy, Near-Infrared; Stereoisomerism | 2015 |
Dicyanovinylnaphthalenes for neuroimaging of amyloids and relationships of electronic structures and geometries to binding affinities.
Topics: 2-Naphthylamine; Acrylonitrile; Alzheimer Disease; Amyloid beta-Peptides; Binding Sites; Binding, Competitive; Crystallography, X-Ray; Humans; Kinetics; Models, Molecular; Molecular Conformation; Molecular Structure; Neuroimaging; Plaque, Amyloid; Protein Binding | 2012 |